Send Inquiry

Request To Call Back

Trajenta Linagliptin 5mg Tablets

Get a Price/Quote

MOQ : 10 Pieces

Trajenta Linagliptin 5mg Tablets Specification

Molecular Formula
C25H28N8O2

Acid Value
Not applicable (relevant for oils/fats)

Suitable For
Adults

Assay
NLT 98% (as per pharmacopeial standards)

Dosage Guidelines
As directed by the physician

Physical Form
Tablet

Solubility
Sparingly soluble in water

Refractive Rate
Not applicable (solid dosage form)

Pacakaging (Quantity Per Box)
90 tablets (9x10)

Purity
Pharmaceutical grade

Appearance
Film-coated tablets

CAS No
668270-12-0

Melting Point
186-188C (for Linagliptin base)

HS Code
30049099

Type
Antidiabetic medication

Ingredients
Linagliptin 5mg per tablet, excipients

Feature
DPP-4 Inhibitor for Type 2 Diabetes Management

Shelf Life
24-36 months from manufacturing date

Storage Instructions
Store below 30C; protect from moisture

Packaging Type
Boxed blister strips

Shape
Round

Brand Name
Trajenta

Marketed By
Boehringer Ingelheim

Warnings
Not for use in Type 1 diabetes or for the treatment of diabetic ketoacidosis

Instructions for Handling
Keep out of reach of children, use under medical supervision

Route of Administration
Oral

Regulatory Approval
Approved by major regulatory authorities (US FDA, EMA, etc.)

Dosage Form
Solid

Indication
Type 2 Diabetes Mellitus

Color
White or off-white

Batch/Lot Number
As per individual pack

Generic Name
Linagliptin

Prescription Status
Prescription only

Inactive Ingredients
Lactose monohydrate, maize starch, pregelatinised starch, mannitol, magnesium stearate, etc.

Additional Information
Also available in multiple markets including Canada, EU, USA, UK, and Australia

Contraindications
Hypersensitivity to Linagliptin or any excipient

Therapeutic Class
Oral hypoglycemic agent

Trajenta Linagliptin 5mg Tablets About

Discover ace diabetes control with Trajenta Linagliptin 5mg Tablets-your illustrious solution for Type 2 Diabetes Mellitus, now at an unbeatable price for a limited time. Marketed by the renowned Boehringer Ingelheim, these ravishing, film-coated, white or off-white round tablets feature 5mg Linagliptin per dose and a DPP-4 inhibition profile trusted globally. Manufactured to pharmaceutical grade standards and approved by leading authorities (US FDA, EMA), Trajenta empowers adults with solid performance and purity (NLT 98%). Find your path to stable blood sugar control with Trajenta today.

Primary Competitive Advantages, Usage Suitability & Application Surface

Trajenta Linagliptin 5mg Tablets stand out with ace efficacy, global regulatory approval, and illustrious manufacturing standards. Suitable exclusively for adult patients with Type 2 Diabetes Mellitus, the tablet's surface design ensures ease of oral administration. Backed by Boehringer Ingelheim's notable reputation, these tablets deliver reliable and ravishing glycemic management. Trajenta's DPP-4 inhibitor mechanism, convenient daily dosing, and boxed blister packaging further elevate usability and patient compliance in a variety of clinical and home settings.

Certifications, Main Domestic Market & Packaging Information

Trajenta Linagliptin 5mg Tablets come with certifications from major regulatory agencies including US FDA and EMA, ensuring top-tier safety and efficacy. They are widely available in domestic and international markets such as India, the USA, UK, EU, Canada, and Australia. Order completion involves boxed blister strips with 90 tablets (9x10). Estimate delivery timelines based on your region, with prompt and secure transportation to maintain quality, supported by clear batch/lot labeling and robust packaging protocols.

FAQ's of Trajenta Linagliptin 5mg Tablets:

Q: How should Trajenta Linagliptin 5mg Tablets be administered?

A: Trajenta Linagliptin 5mg Tablets are intended for oral administration and should be taken once daily as directed by a physician. Always follow your healthcare provider's instructions for dosage and usage.

Q: What are the primary benefits of using Trajenta for Type 2 Diabetes?

A: Trajenta offers effective glycemic management for adults with Type 2 Diabetes Mellitus through its DPP-4 inhibitor action. Its illustrious regulatory approvals and simple dosing make it a trusted choice for long-term diabetes care.

Q: When is Trajenta contraindicated and who should avoid it?

A: Trajenta is contraindicated in individuals with hypersensitivity to Linagliptin or any excipients. It is not suitable for those with Type 1 diabetes or diabetic ketoacidosis. Always consult your physician before use.

Q: Where is Trajenta Linagliptin 5mg available for purchase?

A: Trajenta is available in multiple international markets, including India, USA, Canada, EU, UK, and Australia. It is typically dispensed through pharmacies and healthcare facilities under prescription only.

Q: What is the process for ordering and receiving Trajenta tablets?

A: Once a prescription is provided, Trajenta can be ordered through licensed pharmacies. Order completion involves secure packaging in boxed blister strips, and transportation is managed to ensure timely and safe delivery.

Q: How should Trajenta tablets be stored and handled?

A: Store Trajenta tablets below 30C and protect them from moisture. Keep out of reach of children and always use under medical supervision, adhering to handling instructions provided on the package.

Tell us about your requirement